TMO - Thermo Fisher Scientific • Financials

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year	Revenue	EBITDA	Net Inc	Net Mrg	EPS	Equity	ROE	Net Debt Aj	ND/EBITDA Aj	OCF Aj	Capex	FCF	Free Aj	Buyback	Dividend	Payout	DY
12/2016	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
12/2017	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
12/2018	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
12/2019	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
12/2020	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
12/2021	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
12/2022	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
12/2023	42,857	10,265	-	14%	15	46,735	13%	26,837	2.6	8,128	-1,479	-3,622	6,649	-3,000	-523	8.7%	0.26%
12/2024	42,879	10,445	-	15%	17	49,584	13%	25,705	2.5	8,366	-1,400	-6,792	6,966	-4,000	-583	9.2%	0.29%
12/2025	44,556	10,526	-	15%	18	53,407	13%	29,280	2.8	7,508	-1,525	1,801	5,983	-3,000	-636	9.5%	0.29%

To see all financials—including updated, you must be Premium.